JP2007500692A - 乳房炎及び耳障害を治療するための分散性医薬組成物 - Google Patents

乳房炎及び耳障害を治療するための分散性医薬組成物 Download PDF

Info

Publication number
JP2007500692A
JP2007500692A JP2006521704A JP2006521704A JP2007500692A JP 2007500692 A JP2007500692 A JP 2007500692A JP 2006521704 A JP2006521704 A JP 2006521704A JP 2006521704 A JP2006521704 A JP 2006521704A JP 2007500692 A JP2007500692 A JP 2007500692A
Authority
JP
Japan
Prior art keywords
composition
oil
ear
acid
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2006521704A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007500692A5 (ru
Inventor
ナンシー・ジーン・ブリテン
ニキ・アン・ウォルドロン
ジェフリー・リン・ウォッツ
ジョン・ウォルター・ホールバーグ
ジョン・ウィリアム・バーンズ・ザ・セカンド
Original Assignee
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファルマシア・アンド・アップジョン・カンパニー・エルエルシー filed Critical ファルマシア・アンド・アップジョン・カンパニー・エルエルシー
Publication of JP2007500692A publication Critical patent/JP2007500692A/ja
Publication of JP2007500692A5 publication Critical patent/JP2007500692A5/ja
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Packages (AREA)
  • Medicinal Preparation (AREA)
JP2006521704A 2003-07-31 2004-07-19 乳房炎及び耳障害を治療するための分散性医薬組成物 Abandoned JP2007500692A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49217803P 2003-07-31 2003-07-31
PCT/IB2004/002474 WO2005009472A2 (en) 2003-07-31 2004-07-19 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Publications (2)

Publication Number Publication Date
JP2007500692A true JP2007500692A (ja) 2007-01-18
JP2007500692A5 JP2007500692A5 (ru) 2007-09-06

Family

ID=34103028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006521704A Abandoned JP2007500692A (ja) 2003-07-31 2004-07-19 乳房炎及び耳障害を治療するための分散性医薬組成物

Country Status (13)

Country Link
EP (1) EP1656159A2 (ru)
JP (1) JP2007500692A (ru)
KR (1) KR100807414B1 (ru)
CN (1) CN1812814A (ru)
AU (1) AU2004258746A1 (ru)
BR (1) BRPI0412923A (ru)
CA (1) CA2529405A1 (ru)
IL (1) IL171893A0 (ru)
MX (1) MXPA06001192A (ru)
NO (1) NO20055466L (ru)
RU (1) RU2329064C2 (ru)
WO (1) WO2005009472A2 (ru)
ZA (1) ZA200600850B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018536708A (ja) * 2015-11-03 2018-12-13 ゾエティス・サービシーズ・エルエルシー ゾル−ゲルポリマー組成物及びそれらの使用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1740214B1 (en) * 2004-04-22 2007-10-03 Pfizer Products Incorporated Method of stabilizing disordered cefovecin sodium salt
NZ702087A (en) * 2012-06-29 2016-12-23 Bayer Animal Health Gmbh Pharmaceutical compositions and treatment of mastitis
EP3033074A1 (en) * 2013-08-12 2016-06-22 Novartis AG Method for treating otic infections after tympanostomy tube placement
CN104622875B (zh) * 2015-02-12 2017-05-10 江西博莱大药厂有限公司 一种抗奶牛乳腺炎的乳房注入药剂及其制备方法
RU2663070C1 (ru) * 2017-05-04 2018-08-01 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ лечения отомикоза

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9701731A (es) * 1995-06-06 1997-10-31 Bayer Ag Composiciones anti-bacterianas oticas, no-irritantes, no-sensibles y no-toxicas para el oido.
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US20010049366A1 (en) * 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018536708A (ja) * 2015-11-03 2018-12-13 ゾエティス・サービシーズ・エルエルシー ゾル−ゲルポリマー組成物及びそれらの使用

Also Published As

Publication number Publication date
NO20055466D0 (no) 2005-11-18
WO2005009472A2 (en) 2005-02-03
CN1812814A (zh) 2006-08-02
BRPI0412923A (pt) 2006-09-26
KR20060033031A (ko) 2006-04-18
MXPA06001192A (es) 2006-04-11
ZA200600850B (en) 2007-05-30
KR100807414B1 (ko) 2008-02-25
CA2529405A1 (en) 2005-02-03
EP1656159A2 (en) 2006-05-17
AU2004258746A1 (en) 2005-02-03
RU2329064C2 (ru) 2008-07-20
WO2005009472A3 (en) 2005-04-07
IL171893A0 (en) 2006-04-10
RU2006102665A (ru) 2006-06-10
NO20055466L (no) 2006-04-21

Similar Documents

Publication Publication Date Title
KR100765614B1 (ko) 유방염 및 이질환 치료용 분산성 제약 조성물
EP1608407B1 (en) Dispersible formulation of an anti-inflammatory agent
RU2319508C2 (ru) Диспергируемый препарат противовоспалительного агента
US20080153894A1 (en) Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
US20050009931A1 (en) Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
US20050004098A1 (en) Dispersible formulation of an anti-inflammatory agent
US20040033938A1 (en) Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
JP2007500692A (ja) 乳房炎及び耳障害を治療するための分散性医薬組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070719

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070719

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20090128